Summit Securities Group’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding GDRX
FPM
LCM
SLG
PTC
Summit Securities Group's GDRX Position: Q2 2025 in Review
Summit Securities Group sold out of GoodRx Holdings (GDRX) in Q2 2025, closing a stake of 551 shares — an estimated $2.43K sold.
Summit Securities Group first reported a position in GDRX in Q1 2025 and held it in 1 quarter. The position peaked at $2.43K in Q1 2025. 182 funds tracked by Wall St. Rank hold GDRX as of Q2 2025.
- Summit Securities Group reported no remaining GoodRx Holdings position as of Q2 2025 after selling out during the quarter.
- Summit Securities Group sold 551 GoodRx Holdings shares in Q2 2025, an estimated $2.43K.
- Summit Securities Group first reported a position in GoodRx Holdings in Q1 2025 and held it in 1 quarter.
- Summit Securities Group's GoodRx Holdings position peaked at $2.43K in Q1 2025.
- 182 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2025.
Based on Summit Securities Group's 13F filing for Q2 2025, filed 12 Aug 2025.